← All stocks

Harmony Biosciences Holdings, Inc.

HRMY Net selling

CIK 0001802665 #1965 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$4.30M

$1.01M on a plan · $3.05M straight out of an exercise

Sold at will

$230.91K

1 of 10 sales

Net

−$4.30M

−$230.91K against sales at will

By person

8 insiders · 10 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Kapadia Sandip

CHIEF FINANCIAL OFFICER

—

$1.80M (4) scheduled

−$1.80M

24,521

0.0421%

$1.06M

+13.7%

Budur Kumar

CHIEF MEDICAL OFFICER

—

$1.45M (4) scheduled

−$1.45M

13,115

0.0225%

$565.27K

+1,205%

Dayno Jeffrey M.

PRESIDENT, CEO

—

$1.04M (2) scheduled

−$1.04M

7,346

0.0126%

$316.62K

—

Marshman Fund Trust II entity

10% owner

—

6,051,120

10.39%

$260.81M

−43.2%

Zaeske Adam H.

CHIEF COMMERCIAL OFFICER

—

4,327

0.0074%

$186.50K

—

Serafin Andrew

CHIEF STRATEGY OFFICER

—

1,474

0.0025%

$63.53K

—

Valor IV Pharma Holdings, LLC entity

10% owner

—

0.0000%

$0.00

−100.0%

Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

—

0.0000%

$0.00

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Budur Kumar

4 Sep 2026

CHIEF MEDICAL OFFICER

Sell

5,500

$41.98

$230.91K

Show all 10 transactions →

What was left out

Form 4 filings counted 23

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 3

Sales straight out of an exercise 6

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 232,284

History held since 20 Aug 2020